Peptide record

TPDB01000

ACE inhibitor ACE inhibitors Antihypertensive Antioxidant standard
5 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB01000
ACE inhibitor
ACE inhibitors Antihypertensive Antioxidant
Cardiometabolic peptides Functional / health-promoting peptides
Peptipedia AHTPDB AHTpin AoXpDb
standard
No
A 5-aa standard-residue multi-activity (ACE inhibitors, Antihypertensive, and Antioxidant) peptide sequence curated from Peptipedia, AHTPDB, AHTpin, and other sources, with an available 3D structural model.
Sequence
LDIQK
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C27H49N7O9
ARNCEGHMFPSTWYV
DQILK
615.73
6.75
1
1
2
-0
1.99
-0.520
156.00
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
0
0.00
1
Residue Composition
number
0
A
0
R
0
N
1
D
0
C
0
E
1
Q
0
G
0
H
1
I
1
L
1
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 1 C: 0 E: 0 Q: 1 G: 0 H: 0 I: 1 L: 1 K: 1 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
5 reviewed residue count
C27H49N7O9 sequence-only estimate (linear, free termini)
615.73 sequence-only estimate (linear, free termini)
6.75 sequence-only estimate (linear, free termini)
-0 sequence-only estimate (linear, free termini)
1.99 sequence-only estimate (linear, free termini)
-0.520 sequence-only estimate (linear, free termini)
615.7175 Activity
615.3580 Activity
Evidence Records 2 records
Evidence 1 Activity

Activity

IC50
ACE inhibitors
17.00 µM
Inhibitor of Angiotensin-converting enzyme (EC 3.4.15.1) (MEROPS ID: M02-001)
ACE inhibitor
ah

Source & Reference

NA
Meisel H., Walsh D. J., Murray B., FitzGerald R. J.
ACE inhibitory peptides. in: Nutraceutical proteins and peptides in health and disease. Mine Y., Shahidi F. (Eds.), CRC Taylor & Francis Group, Boca Raton, London, New York, 269-315, 2006
2006
book

Other

5
BIOPEP-UWM database of bioactive peptides N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(CCCCN)C(=O)O InChI=1S/C27H49N7O9/c1-5-15(4)22(34-25(40)19(13-21(36)37)33-23(38)16(29)12-14(2)3)26(41)31-17(9-10-20(30)35)24(39)32-18(27(42)43)8-6-7-11-28/h14-19,22H,5-13,28-29H2,1-4H3,(H2,30,35)(H,31,41)(H,32,39)(H,33,38)(H,34,40)(H,36,37)(H,42,43)/t15-,16-,17-,18-,19-,22-/m0/s1 InChIKey=YBSCDHHMDIRQTJ-LXYCOOOUSA-N
Evidence 2 Activity

Activity

IC50
Antihypertensive
17.00 µM
Inhibitor of Angiotensin-converting enzyme (EC 3.4.15.1) (MEROPS ID: M02-001)
ACE inhibitor
ah

Source & Reference

AHTPDB
Meisel H., Walsh D. J., Murray B., FitzGerald R. J.
ACE inhibitory peptides. in: Nutraceutical proteins and peptides in health and disease. Mine Y., Shahidi F. (Eds.), CRC Taylor & Francis Group, Boca Raton, London, New York, 269-315, 2006
2006
book

Other

Source Activity Label Source Definition
Antihypertensive
AHTPDB manually curated experimentally validated antihypertensive peptide annotation.
5
BIOPEP-UWM database of bioactive peptides N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(CCCCN)C(=O)O InChI=1S/C27H49N7O9/c1-5-15(4)22(34-25(40)19(13-21(36)37)33-23(38)16(29)12-14(2)3)26(41)31-17(9-10-20(30)35)24(39)32-18(27(42)43)8-6-7-11-28/h14-19,22H,5-13,28-29H2,1-4H3,(H2,30,35)(H,31,41)(H,32,39)(H,33,38)(H,34,40)(H,36,37)(H,42,43)/t15-,16-,17-,18-,19-,22-/m0/s1 InChIKey=YBSCDHHMDIRQTJ-LXYCOOOUSA-N
Additional Detail Fields 1 fields
5